In patients with malignant glioma, it was found that levels of TGF-β protein were high in the blood serum and the tumor tissue; at the same time, these levels were correlated with the malignancy of the tumor, the stage of tumor development, and patient prognosis [61,62]. Here, TGFB1 is linked to malignant glioma.